Cannabinoids

Subject Index 765

lophotrochozoan 292
lower urinary tract symptoms 723
LTD 466
LTP 466
lung 346, 403
lung cancer 397, 403
luteinizing hormone 562
LY320135 10, 21, 23, 32, 35, 36
lymphocyte 409
lymphocytes 391, 395, 403
lysophospholipid receptors 291

macrophage inflammatory protein

(MIP)-1α 397

macrophage processing of antigens
393
macrophage(s) 392, 393, 403, 408, 616
MAFP 192, 197
magnetic resonance imaging 426
MAPK 61
marijuana 670
marijuana cigarette 437
medial septum 311
medium spiny neuron 354
medium spiny neurons 311
melanocortin receptors 291
membrane transporter 198
memory 448
consolidation 457
episodic 450
facilitation 457
long-term 448
olfactory 458
recognition 448
reference 452, 454
short-term 448, 459
social recognition 458
spatial 452
working 454
meningitis 413
mEPSCs 350
mesenterial vessels 346
metabolism 427, 657
methanandamide (R-(+)-methan-
andamide) 8, 15, 16, 18,
20, 26, 32, 33, 35, 36, 236

methylarachidonoylfluorophospho-

nate 191

MGL seemonoacylglycerol lipase

microglialcells 2,5,7,34,35,62,65,

84, 104, 105, 127, 152, 166,

318, 388, 393, 401, 405–408,

488, 489, 499, 530–532, 633,

637

glial activation 489, 499

microPET 439

MIP-1β 397

mIPSCs 342, 350

mollusc 285, 292

monoacylesters 196

monoacylglycerol lipase (MGL) 6,

188, 194, 288, 289

Kmvalues 196

biochemical characterisitics

194

brain, distribution of 194

catalytic triad 194

inhibitors 198

molecular characteristics 194

regulation of 197

subcellular distribution 195

substrate specificity 196

translocate 195

monoamines 342, 343

monocytes 398

monoglyceride lipase seemono-

acylglycerol lipase

Monte Carlo/simulated annealing

conformationalmemories 264

motor coordination 438

motor disorders 490

dyskinesia 496–498

Huntington’sdisease 483–485,

491, 492, 496

multiple sclerosis (MS) 398,

412, 491, 498, 723

Parkinson’s disease 483, 491,

495, 496, 728

Tourette’s syndrome 491, 498,

728

motor function 480

activation 483